Fatal graft-versus-host disease following HLA-mismatched donor lymphocyte infusion

被引：0
|
作者：
PJ Amrolia
K Rao
O Slater
A Ramsay
PA Veys
DKH Webb
机构：
[1] Great Ormond Street Hospital for Sick Children,Departments of Bone Marrow Transplantation and Pathology
来源：
Bone Marrow Transplantation | 2001年 / 28卷
关键词：
HLA-mismatched; donor lymphocyte infusion; graft-versus-host disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
We report the case of a 10-year-old boy with molecular relapse of CML following unrelated donor BMT who developed fatal grade 4 acute GVHD of the gut and liver following one antigen-mismatched donor lymphocyte infusion. Previous experience of donor lymphocyte infusion in the HLA-mismatched setting is reviewed and the role of adoptive immunotherapy in this situation is discussed. Bone Marrow Transplantation (2001) 28, 623–625.
引用
收藏
页码：623 / 625
页数：2
相关论文
共 50 条
  • [41] Graft-versus-host disease following living donor liver transplantation: high risk when the donor is HLA-homozygous
    Calmus, Y
    JOURNAL OF HEPATOLOGY, 2004, 41 (03) : 505 - 507
  • [42] Lymphopenia promotes the development of graft-versus-host disease upon donor leukocyte infusion
    Sachs, Jessica
    Sykes, Megan
    BLOOD, 2007, 110 (11) : 650A - 650A
  • [43] Graft-versus-host disease after granulocyte infusion
    Barrenetxea, C
    Zuazu, F
    Iraheta, S
    Purroy, N
    BONE MARROW TRANSPLANTATION, 2006, 37 : S98 - S98
  • [44] SELF-TOLERANCE TO HOST AND DONOR FOLLOWING HLA-MISMATCHED BONE-MARROW TRANSPLANTATION
    DEVILLARTAY, JP
    GRISCELLI, C
    FISCHER, A
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1986, 16 (02) : 117 - 122
  • [45] Basiliximab for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease After Unmanipulated HLA-Mismatched/Haploidentical Hematopoietic Stem Cell Transplantation
    Wang, J. Z.
    Liu, K. Y.
    Xu, L. P.
    Liu, D. H.
    Han, W.
    Chen, H.
    Chen, Y. H.
    Zhang, X. H.
    Zhao, T.
    Wang, Y.
    Huang, X. J.
    TRANSPLANTATION PROCEEDINGS, 2011, 43 (05) : 1928 - 1933
  • [46] Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation
    Ikegame, Kazuhiro
    Yoshihara, Satoshi
    Taniguchi, Yuki
    Kaida, Katsuji
    Inoue, Takayuki
    Okada, Masaya
    Taniguchi, Kyoko
    Hasei, Hitomi
    Tamaki, Hiroya
    Fujioka, Tatsuya
    Kato, Ruri
    Soma, Toshihiro
    Ogawa, Hiroyasu
    EXPERIMENTAL HEMATOLOGY, 2011, 39 (08) : 880 - 890
  • [47] Improved Immune Reconstitution After Bortezomib-Based Acute Graft-Versus-Host Disease Prophylaxis for HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Allogeneic Transplantation
    Koreth, John
    Stevenson, Kristen E.
    Kim, Haesook T.
    McDonough, Sean
    Herrera, Maria I.
    Reynolds, Carol G.
    Murga, Gorka
    Ho, Vincent T.
    Cutler, Corey
    Armand, Philippe
    Soiffer, Robert J.
    Antin, Joseph H.
    Alyea, Edwin P., III
    Ritz, Jerome
    BLOOD, 2009, 114 (22) : 25 - 25
  • [48] HLA homozygosity and the risk of graft-versus-host disease
    Martin, PJ
    Petersdorf, EW
    Anasetti, C
    Hansen, JA
    TISSUE ANTIGENS, 1997, 50 (02): : 119 - 123
  • [49] HLA Class II Upregulation During An Ongoing Viral Infection Can Lead to HLA-DP Directed Graft-Versus-Host Disease After HLA-DPB1 Mismatched CD4+Donor Lymphocyte Infusion
    Stevanovic, Sanja
    van Bergen, Cornelis A. M.
    van Luxemburg-Heijs, Simone A. P.
    Harskamp, Jessica C.
    Halkes, C. J. M.
    Griffioen, Marieke
    Falkenburg, J. H. Frederik
    BLOOD, 2011, 118 (21) : 1320 - 1321
  • [50] GRAFT-VERSUS-HOST DISEASE FOLLOWING ECMO
    HATLEY, RM
    REYNOLDS, M
    PALLER, AS
    CHOU, P
    JOURNAL OF PEDIATRIC SURGERY, 1991, 26 (03) : 317 - 319
12345